Provectus shareholders approve reverse stock split authorization and elect directors at annual meeting

PROVECTUS BIOPHARMACEUTICALS, INC.

Stockholders elected all four director nominees: Bailey, Lacey, Pershing, Rodrigues, with >200M votes for each.
Advisory say-on-pay approved: 195.7M for, 15.1M against, 0.4M abstentions; 138.8M broker non-votes.
Ratified CBIZ CPAs P.C. as independent auditor for 2025: 337.9M for, 6.2M against, 5.8M abstentions.
Authorized board to implement reverse stock split at ratio between 1:10 and 1:50; 326.8M for, 18.2M against.
Authorized reduction in authorized shares by same reverse split ratio; 330.5M for, 16.8M against.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.